CIGL’s business activities are currently undertaken by following key subsidiaries:
Capital Impetus Asset Management Limited (CIAML) – an asset management company domiciled in the Cayman Islands managing assets and investments in the Greater American and European regions. CIAML primarily focuses on the management of private equity funds, fund of funds and alternative investments.
China Capital Impetus Asset Management Pte. Ltd. (CCIAM) – a Registered Fund Management Company in Singapore and regulated by the Monetary Authority of Singapore. CCIAM focuses on the management of private equity funds and fund of funds mainly in China and the Southeast Asia countries.
Capital Impetus Advisory Pte Ltd. (CIAPL) – a Singapore incorporated company that serves as a matching platform for SGX listed companies in the areas of M&A, reorganization, real estate trust, commercial trust, and the design of fund based investment products.
Capital Impetus Asset Management LLC (CIAMLLC) – a New York, U.S. incorporated asset management company that established by the end of 2016, the core business of this company is the investment and management of funds in the U.S. region.
狮玺（上海）商务咨询有限公司－ a consultancy company that domiciled in Shanghai Free Trade Zone, it is a wholly subsidiary of CIAML, this company and its Beijing subsidiary are primarily focusing on the consultancy for Chinese domestic customers on overseas capital market listing and M&A.
CIGL has also established CEL Impetus Corporate Finance Pte. Ltd (“CEL Impetus”) in Singapore with a wholly owned subsidiary of China Everbright Holdings (Hong Kong Listing Code: 00165). CEL Impetus holds a Capital Market Service (CMS) licence issued by the Monetary Authority of Singapore (“MAS”) and Singapore Exchange (“SGX”).